Pancreatic Cancer Risk Much Higher for Certain Group, Study Suggests
(MedPage Today) -- Low-risk pancreatic cystic lesions were associated with a long-term risk of pancreatic cancer, according to a retrospective ...
(MedPage Today) -- Low-risk pancreatic cystic lesions were associated with a long-term risk of pancreatic cancer, according to a retrospective ...
(MedPage Today) -- The investigational drug daraxonrasib, now available through an early access program, demonstrated promising efficacy in previously treated ...
Data presented in April suggest daraxonrasib may be far more effective than previous treatments for pancreatic cancer Source: www.thehindu.com Medical ...
(MedPage Today) -- The FDA has given the green light to an expanded access program (EAP) for the investigational pancreatic ...
(MedPage Today) -- In a Medicare population with inflammatory bowel disease (IBD), no higher risk of major cardiovascular events such ...
(MedPage Today) -- SAN DIEGO -- Two phase I/II studies showed that the investigational RAS(ON) inhibitor daraxonrasib had a manageable ...
(MedPage Today) -- Setidegrasib showed promising efficacy in patients with previously treated advanced KRAS G12D-mutated pancreatic ductal adenocarcinoma (PDAC) or ...
(MedPage Today) -- Interval colorectal cancers (CRCs) were lower when patients' endoscopists had a better sessile serrated lesion detection rate ...
Scientists have uncovered a hidden partnership between pancreatic cancer and the nervous system. Support cells in the pancreas lure nerve ...
(MedPage Today) -- The FDA approved a tumor treating fields (TTFields) device for locally advanced pancreatic cancer, the first therapy ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.